Impilo Holding AB

Private Equity Exempt reporting adviser
Stockholm, Sweden LinkedIn

AUM

$442.8M
Private fund assets

Private funds

1
Private Equity 1

Private fund assets

$442.8M
Gross asset value

Employees

—

Last Form D raise

Sep 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

People(4)

Owners and executive officers named on the firm's SEC Form ADV.

C
Carl Edlund
Chairman of the Board of Directors, Chief Executive Officer and Partner
Source: SEC Form ADV
C
Carolina Elisabeth Dahl
Director and Partner
Source: SEC Form ADV
E
Erik Fagerlund
Director, Chief Operating Officer and Partner
Source: SEC Form ADV
L
Lars Steien
Director and Partner
Source: SEC Form ADV

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Impilo Orphan Drugs ABPrivate Equity$442.8M$80.5M12Sep 2024Cold

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
333114
SEC file number
802-131579

Sources